* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download BCHEM 254 – METABOLISM IN HEALTH AND DISEASES II Lecture
Survey
Document related concepts
Metalloprotein wikipedia , lookup
Oxidative phosphorylation wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Point mutation wikipedia , lookup
Gel electrophoresis of nucleic acids wikipedia , lookup
Polyadenylation wikipedia , lookup
Genetic code wikipedia , lookup
Epitranscriptome wikipedia , lookup
Fatty acid synthesis wikipedia , lookup
Citric acid cycle wikipedia , lookup
Fatty acid metabolism wikipedia , lookup
Adenosine triphosphate wikipedia , lookup
Oligonucleotide synthesis wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Biochemistry wikipedia , lookup
Transcript
BCHEM 254 – METABOLISM IN HEALTH AND DISEASES II Lecture 3 Nucleotide Catabolism Christopher Larbie, PhD Introduction Nucleotides are the building blocks of nucleic acids, the information carrying macromolecules of the cell. The two types of nucleic acids are ribonucleic acid, called RNA, and deoxyribonucleic acid, called DNA. Nucleotides consist of three parts: 1. a sugar (either ribose (in RNA only) or 2-deoxyribose (in DNA only)). 2. a nitrogen base (a purine or pyrimidine ring) attached to the sugar 1' carbon. 3. a phosphate group or groups, usually attached to the sugar 5' carbon. Nucleotides are important for reasons besides being precursors of nucleic acids. Most of them provide energy used to drive biochemical reactions. ATP is the most commonly used source, but GTP is used in protein synthesis as well as a few other reactions. UTP is the source of energy for activating glucose (glycogen synthesis) and galactose. CTP is an energy source in lipid metabolism (glycerolipid synthesis). AMP is part of the structure of coenzymes like NAD and Coenzyme A. We can synthesize nucleotides by both de novo (new synthesis from scratch) and salvage pathways and reuse those we already have. Nomenclature Sugars: Nucleotides contain one of two kinds of sugar. Deoxyribonucleotides derive their name from the fact that they contain deoxyribose whereas ribonucleotides contain the sugar ribose. The sugar ribose is a product of the pentose phosphate pathway. Deoxyribose is not synthesized, as such, in the cell but, as we shall see, is produced by action of the enzyme ribonucleotide reductase on ribonucleotide diphosphates. 1|Page ©2014 Dr. Christopher Larbie Nitrogen Bases: There are two kinds of nitrogen-containing bases in nucleic acids: purines and pyrimidines. Purines consist of two fused nitrogen-containing rings with a total of nine ring atoms. Pyridmidines have only a six-membered nitrogencontaining ring. Purines and pyrimidines are "flat", hydrophobic, aromatic molecules that absorb ultraviolet light (260 nm). There are two purines and three pyrimidines that are of concern to us. Cytosine is found in both DNA and RNA. Uracil is usually found only in RNA and thymine is normally only in DNA. There are exceptions, however. Sometimes transfer RNA molecules will contain some thymine as well as uracil (a few DNA molecules also have uracil instead of thymine). Nucleosides (base and sugar): Covalently linking carbon 1 of a sugar (ribose or 2deoxyribose) with a nitrogen base (N 9 of a purine base or N 1 of a pyrimidine base) creates a nucleoside. Purine nucleoside names end in -osine and pyrimidine nucleoside names end in -idine. The convention is to number the ring atoms of the base normally and to use l', etc. to distinguish the ring atoms of the sugar. Unless otherwise specified, the sugar is assumed to be ribose. To indicate that the sugar is 2'-deoxyribose, a d- is placed before the name. Nucleotides (base, sugar, and phosphate): Nucleosides with phosphate(s) linked on the sugar portion of the molecule are called nucleotides. Nucleotides with one phosphate are also called nucleoside monophosphates (NMP); those with two phosphates are nucleoside diphosphates (NDP); and those with three phosphates are nucleoside triphosphates (NTP). Thus, ATP is a nucleotide and it is also called a nucleoside triphosphate. Generally, the phosphate is in ester linkage to carbon 5' of the sugar. When more than one phosphate is present, they are generally in acid anhydride linkages to each other. If the phosphate is on the 5' carbon, no position designation in the name is required. If the phosphate is in any other position, however, the position must be designated. For example, 3'-5' cAMP indicates that a single phosphate is in ester linkage to both the 3' and 5' hydroxyl groups of an adenosine molecule and forms a cyclic structure. 2'-GMP would indicate that a phosphate is in ester linkage to the 2' hydroxyl group of a guanosine. Salvage of Nucleotide Bases Before considering de novo synthesis of nucleotides, it is important to remember that the bases used in nucleotides can come both from new synthesis (de novo) or from salvage of bases previously made. The figure below schematically depicts breakdown/synthesis of nucleic acids along with breakdown/synthesis of nucleotides. 2|Page ©2014 Dr. Christopher Larbie Note that, starting at the bottom, nucleobases (such as thymine, guanine, etc.) and nucleoside monophosphates can be interconverted by action of the enzyme phosphoribosyl transferase on them in the presence of 5-phospho-α-D-ribosyl-1pyrophosphate (PRPP). Notice also the central role that mononucleotides have in the process. They can be converted to nucleoside triphosphates and DNA, or can be converted to either nucleosides (by action of nucleotidases) or broken down to nucleobases (reversal of phosphoribosyl transferase reaction). Ribonucleotide reductase produces dADP, dGDP, dCDP and dUDP. These diphosphodeoxyribonucleosides are phosphorylated by ATP to generate the dNTPs. The enzyme is the same nucleoside diphosphate kinase that phosphorylates the ribonucleotides. dNDP + ATP → dNTP + ADP Nucleoside diphosphate kinase NDP + ATP → NTP + ADP Nucleoside diphosphate kinase Dietary Nucleic Acids Nucleic acids are ubiquitous biomolecules. A significant amount of nucleic acids are ingested in our diets. Nucleic acids are digested in our intestinal tract to nucleotides by various nucleases and phosphodiesterases. Nucleotides are then dephosphorylated by nonspecific phosphatases. NMP + H2O → Nucleoside + Pi 5’-nucleotidase The nucleosides are hydrolyzed by nucleosidases to release the bases. Nucleoside + H2O → base + ribose 3|Page ©2014 Dr. Christopher Larbie The ribose liberated in this reaction can be catabolized for energy. And is the only portion of the nucleotide that can be used as a source of metabolic energy. Very little of the nucleic acids ingested in our diets become incorporated into the nucleic acids in our cells. Most of the ingested bases are excreted. The salvage pathways are to continuously recycle cellular constituents not incorporated dietary bases. Purine Nucleotide Catabolism The purine nucleotides are catabolized by the following pathways. GMP is converted into guanosine by 5’-nucleotidase. Next guanosine is converted into guanine and ribose-1-phosphate by purine nucleoside phosphorylase. Guanine is then converted into xanthine by guanine deaminase. AMP has two degradation pathways. One pathway converts AMP into IMP by AMP deaminase. IMP is dephosphorylated by 5’-nucleotidase to form inosine. Inosine is 4|Page ©2014 Dr. Christopher Larbie broken down into ribose-1-phosphate and hypoxanthine by purine nucleoside phosphorylase. The major pathway begins with dephosphorylating AMP by 5’nucleotidase to form adenosine which is then deaminated by adenosine deaminase to form inosine. Inosine is converted into ribose-1-phosphate and hypoxanthine as previously described. Hypoxanthine is converted into xanthine by xanthine oxidase. Xanthine oxidase then oxidizes xanthine to produce uric acid. Animals excrete uric acid. 5|Page ©2014 Dr. Christopher Larbie Adenosine Deaminase A genetic deficiency of adenosine deaminase causes severe combined immunodeficiency syndrome (SCID). Lack of adenosine deaminase activity causes an inability of B and T lymphocytes to proliferate and produce antibodies. Adenosine deaminase activity is also impaired in other diseases such as AIDS, anaemia, lymphomas and leukemias. Adenosine deaminase deficiency is another target for gene therapy. Gene therapy is the attempt to repair a genetic deficiency by the introduction of a function gene. So far Gene therapy has experienced lots of setbacks. A loss or lack of adenosine deaminase activity causes deoxyadenosine to be converted into dAMP. dAMP is then converted in to dATP. The result is high concentrations of dATP. dATP is a potent inhibitor of deoxynucleotide biosynthesis. Remember that dATP binds to the activity site of ribonucleotide reductase and turns the enzyme off. Pyrimidine Nucleoside Catabolism Pyrimidines are also catabolized as shown. β-Alanine is then deaminated by a transaminase to form Malonic semialdehyde which is then oxidized and converted into malonyl-CoA. Malonyl-CoA as a precursor for fatty acid biosynthesis. βAminoisobutryate is also deaminated by a transaminase to form Methylmalonic semialdehyde which is then oxidized and converted into methylmalonyl-CoA which is converted into succinyl-CoA by methylmalonyl mutase. 6|Page ©2014 Dr. Christopher Larbie